Oaktree Acquisition Corp. II (OACC)
Oaktree Acquisition Corp. II operates in the Shell Companies industry of the Financial Services sector, headquartered in Los Angeles, CA, US. The stock last traded at $10.79, up 0.47% on the session, giving a market capitalisation of $265.2M. On trailing twelve-month figures it carries a trailing P/E of 37.34, a net margin of 0.0%. Its beta of -0.04 implies it has historically moved less than the broad market.
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.
Oaktree Acquisition Corp. II is most often compared with the following Financial Services names: